Personalize My Treatment Registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry where patients consent to provide residual tumor tissue and access to their medical records for data collection. Participants are followed over time to capture information about their illness trajectory and responses to any treatments. They may be recontacted about other research opportunities, including clinical trials. The project relies on biobanking of surplus samples and longitudinal data to support cancer research and potential future discoveries.

Why it matters

Who can join: the full rules

Age of majority in the province of recruitment.

Where it's running

• Jewish General Hospital University Health Centre
  Montreal, Quebec, Canada Recruiting
• Tom Baker Cancer Centre
  Calgary, Alberta, Canada Suspended
• Cross Cancer Institute
  Edmonton, Alberta, Canada Suspended
• Centre Hospitalier Universitaire Dr-Georges-L.-Dumont
  Moncton, New Brunswick, Canada Suspended
• The Moncton Hospital
  Moncton, New Brunswick, Canada Suspended
• QE II Health Sciences Centre
  Halifax, Nova Scotia, Canada Suspended

Study contacts

• Study coordinator: Gerald Batist, MD
• Email: gerald.batist.med@ssss.gouv.qc.ca
• Phone: 514-340-8222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Brachytherapy and Nivolumab Before Surgery for Rectal Cancer

  This small Phase II study tests whether targeted internal radiation therapy followed by two doses of nivolumab can be safely given before rectal cancer surgery to see if it helps the treatment work.

  Recruiting Phase 2 Sir Mortimer B. Davis - Jewish General Hospital · Montreal, Quebec · NCT07645118

• New nerve surgery to help men regain erections after prostate cancer surgery

  This study will try a new nerve graft surgery using the ilioinguinal nerve to help men who lost erections after prostate removal regain erectile function within a year.

  Recruiting Sir Mortimer B. Davis - Jewish General Hospital · Montreal, Quebec · NCT07188064

• Long-term safety of nipple sparing mastectomy for women with genetic breast cancer risk

  This study is testing the long-term safety of nipple-sparing mastectomy for women with a genetic risk of breast cancer to see if it’s a good option for those who want to keep their nipple area.

  Recruiting at 9 sites Sir Mortimer B. Davis - Jewish General Hospital · New Haven, Connecticut and 15 other locations · NCT06888388

• Nerve grafting technique to help preserve erectile function after prostate surgery

  This study is testing a new nerve grafting technique during prostate surgery to see if it can help men keep their erectile function after the operation.

  Recruiting at 2 sites Sir Mortimer B. Davis - Jewish General Hospital · Montreal, Quebec and 1 other locations · NCT06521710

• Detecting and profiling measurable residual disease in multiple myeloma patients

  This study is testing a new way to check for leftover cancer cells in multiple myeloma patients who are in remission after a transplant to see how well their treatment is working.

  Recruiting Sir Mortimer B. Davis - Jewish General Hospital · Montreal, Quebec · NCT05530096

• Using a monitor to predict low blood pressure in surgical patients after surgery

  This study is testing if a special monitor can help doctors predict low blood pressure in patients after they have surgery, so they can act quickly to prevent complications.

  Recruiting Sir Mortimer B. Davis - Jewish General Hospital · Montreal, Quebec · NCT05335174

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.